114 related articles for article (PubMed ID: 26773103)
1. Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18.
Rademacher J; Kill A; Mattat K; Dragun D; Siegert E; Günther J; Riemekasten G
J Rheumatol; 2016 Mar; 43(3):587-91. PubMed ID: 26773103
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
[TBL] [Abstract][Full Text] [Related]
3. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
[TBL] [Abstract][Full Text] [Related]
4. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G of systemic sclerosis patients programs a pro-inflammatory and profibrotic phenotype in monocyte-like THP-1 cells.
Murthy S; Wannick M; Eleftheriadis G; Müller A; Luo J; Busch H; Dalmann A; Riemekasten G; Sadik CD
Rheumatology (Oxford); 2021 Jun; 60(6):3012-3022. PubMed ID: 33230552
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.
Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
8. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting.
Speck D; Kleinau G; Szczepek M; Kwiatkowski D; Catar R; Philippe A; Scheerer P
Front Endocrinol (Lausanne); 2022; 13():880002. PubMed ID: 35518926
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against angiotensin II type 1 receptor (AT1R) and endothelin receptor type A (ETAR) in systemic sclerosis (SSc)-response.
Riemekasten G; Cabral-Marques O
Autoimmun Rev; 2016 Sep; 15(9):935. PubMed ID: 27074525
[No Abstract] [Full Text] [Related]
11. Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.
Avouac J; Riemekasten G; Meune C; Ruiz B; Kahan A; Allanore Y
J Rheumatol; 2015 Oct; 42(10):1801-7. PubMed ID: 26233500
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies.
Civieri G; Iop L; Tona F
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055116
[TBL] [Abstract][Full Text] [Related]
13. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
14. Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis.
Cabral-Marques O; Riemekasten G
Autoimmun Rev; 2016 Jul; 15(7):690-4. PubMed ID: 26970493
[TBL] [Abstract][Full Text] [Related]
15. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis.
Riemekasten G; Philippe A; Näther M; Slowinski T; Müller DN; Heidecke H; Matucci-Cerinic M; Czirják L; Lukitsch I; Becker M; Kill A; van Laar JM; Catar R; Luft FC; Burmester GR; Hegner B; Dragun D
Ann Rheum Dis; 2011 Mar; 70(3):530-6. PubMed ID: 21081526
[TBL] [Abstract][Full Text] [Related]
16. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor.
Lin YJ; Kwok CF; Juan CC; Hsu YP; Shih KC; Chen CC; Ho LT
Biochem Biophys Res Commun; 2014 Aug; 451(2):263-9. PubMed ID: 25088996
[TBL] [Abstract][Full Text] [Related]
18. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
[TBL] [Abstract][Full Text] [Related]
19. Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis.
Tiev KP; Hua-Huy T; Kettaneh A; Gain M; Duong-Quy S; Tolédano C; Cabane J; Dinh-Xuan AT
Eur Respir J; 2011 Dec; 38(6):1355-60. PubMed ID: 21778167
[TBL] [Abstract][Full Text] [Related]
20. Agonistic antibodies in systemic sclerosis.
Moroncini G; Svegliati Baroni S; Gabrielli A
Immunol Lett; 2018 Mar; 195():83-87. PubMed ID: 29032187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
